Startuplinks
Sign in
Impacta VC logo

Impacta VC.

Investment FundChile

Impacta VC invests in impact startups in Latin America. Impacta VC launched a U$7MM Seed Fund in the US to fund tech companies aligned with the SDGs across LATAM that leverage the partner’s network…

Get in touch

Contacts

3 contacts

Partner contacts (email, phone, LinkedIn) are available with a Startuplinks membership. Create a free account to get started.

Create account

Sign in to see the full profile

Investment criteria, portfolio and contacts are available to Startuplinks members.

Sign in

In the news

8 Impact Funds That Will Shape Latin America’s Purpose-Driven Investment Landscape in 2026

Eight impact funds will shape 2026 in LatAm, with measurable theses and financial discipline. They include Vox, IGNIA, NESsT, Alaya, Canary, and Impacta VC.

Impacta VC participated with more than 370 startups and 239 LATAM founders during 2025

Impacta VC wrapped up 2025 with more than 370 startups and 239 founders in its IMSP and IFSP programs, cementing its position as a key player in Latin America’s impact entrepreneurship ecosystem

Impacta VC and Oracle announce strategic alliance to drive the growth of Latin American startups

Impacta VC and Oracle announce a strategic alliance to support Latin American startups with access to AI, cloud, data, and technical support to scale globally.

Impactaland surpasses 7.550 connections, consolidating its position as EtMday’s investment hub

Impactaland 2025 leads as EtMday’s most relevant investment hub, delivering outstanding results: +7.550 effective VC-startup connections and a record number of attendees.

Impacta VC Turns Four and Prepares Major Announcements at ETMday’s Impactaland

Impacta VC celebrates 4 years with a new edition of Impactaland at EtMday 2025, bringing together startups, VCs, and global leaders to drive impact investing.

Impact Ventures PSM Seed Fund Announces Its First Investment in Preventix

Impact Ventures PSM Seed makes its first investment in Preventix, a Mexican startup that developed a noninvasive screening test.